Study Details

General Information

Sagimet NASH 005 EXT

A Phase 2, Multi-Center, Single-Blind, Randomized, Placebo Controlled Study of TVB-2640 in Subjects with Non-Alcoholic Steatohepatitis

Protocol3V2640-CLIN-005
Identifier
UIDf6a16a9b-d361-4980-b27c-7d71af1b7e66
StatusDone - Archived
Phase2
CategoryNASH / Adult
Launch Year2021
NCT Number-
Created2021-04-21 15:46
Last Updated2022-02-18 20:41

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2021-06-17No
Enrollment Open2021-05-20No
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2022-01-14No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohseni, RizwanaRMohseniNo
Recruiter-No
CoordinatorGallardo, MichaelMGallardoNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorSagimet Biosciences
DivisionSagimet Biosciences
TeamSagimet Biosciences
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROProSciento, Inc.
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?